Fundies.
English

Segment disclosures

Company overview

Akoya Biosciences, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 4 retained observations 4 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Single Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=akya:SingleReportableSegmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-3116639000 Unit_Standard_USD_aLB9yImDuUS7L5OosDkPrQ20250513Open filing evidence
2024-01-01 – 2024-12-3181672000 Unit_Standard_USD_mWCCmer0LUGAq1cbdYBTXA20250317Open filing evidence
2024-01-01 – 2024-03-3118350000 Unit_Standard_USD_aLB9yImDuUS7L5OosDkPrQ20250513Open filing evidence
2023-01-01 – 2023-12-3196633000 Unit_Standard_USD_mWCCmer0LUGAq1cbdYBTXA20250317Open filing evidence